Entasis Therapeutics is being acquired by Innoviva in a deal that brings an FDA-ready antibiotic developed to address drug-resistant strains of a bacterium that infects critically ill, immunocompromised patients. Innoviva has been steadily building up its stake in Entasis, an AstraZeneca spinout, over the past two years.
By learning from the past, we may have a much better arsenal against antimicrobial-resistant bacteria in the near future.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
SeLux’s believes its rapid microbe identification and antibiotic susceptibility diagnostic test will inform better clinical choices and reduce reliance on the most powerful antibiotics, thereby preserving their potency for the long-run.
The drug was developed by the non-profit TB Alliance. Some experts have said nonprofit organizations may provide a long-term solution to the growing problem of antibiotic resistance.
In the wake of Achaogen's bankruptcy, experts discussed ways to ensure new treatments are available to combat drug-resistant bacteria that threaten a post-antibiotic world.
With New Enterprise Associates at the helm of the round, the company is setting out to develop antibiotics for drug-resistant bacterial infections.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
An estimated 23,000 deaths can be tied to antibiotic-resistance every year, according to data from the CDC's website.
Dr. Jerome Adams has been sworn in as the nation's 20th Surgeon General and these areas should be his priorities.
With the help of the 2012 GAIN Act, Zavante Therapeutics is breathing new life into a decades-old antibiotic.
Theories from economics could play a role in how we combat antibiotic resistance.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
A team of Israeli researchers have developed a test that can distinguish whether an infection stems from a virus or a bacteria – a simple but potentially impactful screener that could cut down unnecessary use of antibiotics. Hailing from Israel-based biotech MeMed, the overarching goal is to curb antibiotic resistance – which is growing thanks […]
Transatlantic antibiotics maker Nabriva Therapeutics just raised an enormous swath of cash – it just closed a $120 million Series B round to treat serious and highly resistant bacterial infections. It’s validation for a largely underused class of antibiotics – pleuromutilins – and a step in the direction to address global antibiotic resistance. The first, $50 million tranche […]
Yesterday we discussed the pros and cons of President Obama’s plan to tackle the pressing issue of antibiotic-resistant bacteria from critics, which causes 2 million illnesses each year in the United States and 23,000 deaths. Today, the announcement was made officially, and the president has commented on the issue at hand. “There are parts of […]
The White House on Friday will announce a new, five-year plan to curb the spread of antibiotic resistant microbes, Reuters reports – having reviewed a leaked copy of the 60-page document. However, scientists and lawmakers are already finding major flaws in the plan’s approach, Politico is saying. The plan, devised by a government task force led by top White House […]
It’s long been established that copper works as an effective antimicrobial – but it’s still a costly proposition to make every doorknob, keyboard and toilet seat out of the ubiquitous metal. San Diego-area startup LuminOre Copper Touch has developed an alternative solution: It’s created a copper cold spray so that surfaces can be coated with the stuff – at a […]